Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020

替加环素 鲍曼不动杆菌 肉汤微量稀释 粘菌素 美罗培南 抗菌剂 抗药性 头孢菌素 微生物学 抗生素 医学 抗生素耐药性 生物 最小抑制浓度 细菌 铜绿假单胞菌 遗传学
作者
Chih-Hao Chen,Pin-Han Wu,Min‐Chi Lu,Mao‐Wang Ho,Po‐Ren Hsueh
出处
期刊:International Journal of Antimicrobial Agents [Elsevier BV]
卷期号:61 (2): 106707-106707 被引量:18
标识
DOI:10.1016/j.ijantimicag.2022.106707
摘要

This study evaluated the in-vitro activity of multiple classes of antibiotics, including novel β-lactam combination agents, tigecycline and colistin, against carbapenem-resistant (CRAB), multi-drug-resistant (MDRAB) and difficult-to-treat (DTRAB) Acinetobacter baumannii. Minimum inhibitory concentrations (MICs) were determined using the broth microdilution method. Susceptibility profiles and the distribution of selected antimicrobials among countries were illustrated and examined based on the breakpoints of the Clinical and Laboratory Standards Institute, European Committee on Antimicrobial Susceptibility Testing and the US Food and Drug Administration. In total, 847 A. baumannii isolates were evaluated, and 692 isolates were characterized as CRAB, MDRAB or DTRAB. The prevalence of drug-resistant A. baumannii was >70.0% in South Korea, India and China, while the resistance rate of tigecycline was <5.5%. The MICs of meropenem and meropenem/vaborbactam for drug-resistant A. baumannii were equal (both MIC50 and MIC90 were 32 mg/L, range 0.25-32 mg/L). The overall resistance rate remained high for multiple classes of antibiotics, including penicillins, cephalosporins, carbapenems, quinolones and aminoglycosides (>84.0%, >96.0%, >98.0%, >88.0% and >87.0%, respectively), but not colistin or tigecycline (1.1% and 4.3%, respectively). China showed the lowest susceptibility to tigecycline for drug-resistant A. baumannii isolates compared with other countries. In conclusion, the resistance rate of drug-resistant A. baumannii remains high against multiple classes of antimicrobials. Colistin was the most potent agent, followed by tigecycline. The geographic pattern of tigecycline-resistant A. baumannii varied among countries. Therefore, continuous surveillance of A. baumannii resistance profiles in different regions is required.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lyeming完成签到,获得积分10
1秒前
inp完成签到 ,获得积分10
2秒前
领导范儿应助临江jjjj采纳,获得10
2秒前
无花果应助Kelly0606采纳,获得10
3秒前
心态好应助葛葛葛采纳,获得10
4秒前
破晓应助徐远忠采纳,获得10
5秒前
5秒前
5秒前
7秒前
Hello应助kanryu采纳,获得30
8秒前
刘66666完成签到,获得积分10
9秒前
bkagyin应助科研小白采纳,获得10
9秒前
11秒前
顺利发布了新的文献求助10
12秒前
赘婿应助喜悦汉堡采纳,获得10
13秒前
han发布了新的文献求助10
13秒前
酷波er应助xyc采纳,获得10
14秒前
14秒前
16秒前
16秒前
16秒前
jarjar发布了新的文献求助10
16秒前
18秒前
18秒前
安戈发布了新的文献求助20
18秒前
HONG完成签到 ,获得积分10
19秒前
tes02发布了新的文献求助10
19秒前
20秒前
Joao79发布了新的文献求助10
20秒前
夜轩岚发布了新的文献求助10
20秒前
21秒前
21秒前
Raylihuang发布了新的文献求助10
22秒前
lele发布了新的文献求助10
22秒前
23秒前
23秒前
Nole应助疯子星采纳,获得10
23秒前
Chingyi发布了新的文献求助10
24秒前
酷波er应助是问采纳,获得10
24秒前
fate0325发布了新的文献求助10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Reducing Compassion Fatigue, Secondary Traumatic Stress and Burnout 600
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Mammalian Synthetic Biology 500
Auslegungsgeschichte 500
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7639066
求助须知:如何正确求助?哪些是违规求助? 9212206
关于积分的说明 19761593
捐赠科研通 7205836
什么是DOI,文献DOI怎么找? 3275955
关于科研通互助平台的介绍 2437529
邀请新用户注册赠送积分活动 2273219